信使核糖核酸
免疫
医学
病毒学
免疫学
生物
免疫系统
生物化学
基因
作者
Vrinda Gote,Pradeep Kumar Bolla,Nagavendra Kommineni,Arun Butreddy,Pavan Kumar Nukala,Sushesh Srivatsa Palakurthi,Wahid Khan
摘要
mRNA vaccines have been demonstrated as a powerful alternative to traditional conventional vaccines because of their high potency, safety and efficacy, capacity for rapid clinical development, and potential for rapid, low-cost manufacturing. These vaccines have progressed from being a mere curiosity to emerging as COVID-19 pandemic vaccine front-runners. The advancements in the field of nanotechnology for developing delivery vehicles for mRNA vaccines are highly significant. In this review we have summarized each and every aspect of the mRNA vaccine. The article describes the mRNA structure, its pharmacological function of immunity induction, lipid nanoparticles (LNPs), and the upstream, downstream, and formulation process of mRNA vaccine manufacturing. Additionally, mRNA vaccines in clinical trials are also described. A deep dive into the future perspectives of mRNA vaccines, such as its freeze-drying, delivery systems, and LNPs targeting antigen-presenting cells and dendritic cells, are also summarized.
科研通智能强力驱动
Strongly Powered by AbleSci AI